You are here: Industry Insights > HPV

News List

HPV Therapy INO-3106 Demonstrates Clinical Efficacy against Rare Respiratory Tract Tumors americanpharmaceuticalreview
April 11, 2019
HPV Therapy INO-3106 Demonstrates Clinical Efficacy against Rare Respiratory Tract Tumors.
HPV vaccine to thank for 89% decline in cervical cancer pharmatimes
April 10, 2019
A new analysis has found that human papillomavirus (HPV) vaccination of 12 and 13 year old girls has led to an 89% decline in cases of cervical cancer in Scotland.
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer en-cphi.cn
March 07, 2019
The second Phase 3 study initiation announcement made during the International HPV Awareness Day
Hands Don't Spread HPV, Study Finds drugs
February 18, 2019
Human papillomavirus?(HPV) is easily transmitted during sex, but it is unlikely to be passed by the hands, Canadian researchers report....
Inovio’s Synthetic DNA Vaccine Shows Promise in Treating HPV-Related Head & Neck Cancer americanpharmaceuticalreview
January 25, 2019
Inovio Pharmaceuticals announced a second patient with HPV-related head and neck cancer treated with INO-3112 (now called MEDI0457) in a Phase 1 trial achieved ....
Messages for Increasing Parental Confidence in HPV Vaccine ID'd drugs
January 23, 2019
Providing information on the benefits of vaccination, including cancer prevention, and avoiding expressing urgency to vaccinate can increase parent confidence in human papillomavirus (HPV) vaccination....
HPV vaccines continue to dominate cancer vaccines landscape pharmaceutical-technology
January 08, 2019
Cancer vaccines are a type of immunotherapy used to either treat existing cancer or prevent the development of cancer.
HPV Ups Cervical Cancer Risk, Even With No Cellular Signs drugs
December 25, 2018
The presence of certain high-risk human papillomavirus (HPV) types predicts future risk for high-grade cervical cancer even among women with no cellular indications of cancer at baseline, according to a study published online Dec. 10 in?Cancer....
Merck's Gardasil turns in $1B in monster Q3 fiercepharma
December 04, 2018
Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn't look like it'll be changing.
US FDA approves HPV vaccine for men and women aged 27-45 pharmafile
November 20, 2018
The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman between the ages of 27 and 45. Previously the vaccine